Gintuit
Phase 1/2Terminated 0 views this week 0 watching💤 Quiet
Interest: 14/100
14
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Edentulous Alveolar Ridge
Conditions
Edentulous Alveolar Ridge
Trial Timeline
Jul 1, 2013 → Mar 1, 2015
NCT ID
NCT01929954About Gintuit
Gintuit is a phase 1/2 stage product being developed by Organogenesis for Edentulous Alveolar Ridge. The current trial status is terminated. This product is registered under clinical trial identifier NCT01929954. Target conditions include Edentulous Alveolar Ridge.
Hype Score Breakdown
Clinical
9
Activity
0
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01929954 | Phase 1/2 | Terminated |